Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDRA-1: Hydroxychloroquine and Itraconazole in Ovarian Cancer
NCT03081702Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jul 2017
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, itraconazole in epithelial ovarian cancer (EOC), sponsored by University Health Network. Started Jul 2017; status: completed.
02
Drugs
hydroxychloroquineitraconazole
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT03081702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081702.